Max N. Wallace serves as Executive at Humacyte, Inc., where they oversee executive responsibilities. Since joining the company, Max N. Wallace has executed 4 insider transactions totaling $50.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on May 20, 2024 involved purchasing 4,015 shares valued at $24.9K.
Max N. Wallace currently holds 4,015 shares of Humacyte, Inc. (HUMA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Max N. Wallace has been a net buyer of HUMA stock. They have purchased $50.0K and sold $0 worth of shares.
Max N. Wallace's most recent insider trade was on May 20, 2024, when they purchased 4,015 shares at $6.21 per share.
Get notified when new Form 4 filings are submitted
| $6.29 |
| Discretionary |
| Nov 21, 2023 | HUMA | $7.8K | Option Exercise | 6,564 | $1.19 | Discretionary |
| Aug 26, 2021 | HUMA | $0 | Award | 49,986 | $N/A | Discretionary |